candesartan cilexetil has been researched along with Aortic Diseases in 2 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Aortic Diseases: Pathological processes involving any part of the AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the effect of chronic administration of an angiotensin II type-1 receptor antagonist in the development of heart failure due to volume overload in rats." | 1.29 | Angiotensin II type-1 receptor antagonist as well as angiotensin converying enzyme inhibitor attenuates the development of heart failure in aortocaval fistula rats. ( Akioka, K; Nishikimi, T; Ohmura, T; Takeuchi, K; Tani, T; Teragaki, M; Toda, I; Yamagishi, H; Yanagi, S; Yoshiyama, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnstone, MT | 1 |
| Perez, AS | 1 |
| Nasser, I | 1 |
| Stewart, R | 1 |
| Vaidya, A | 1 |
| Al Ammary, F | 1 |
| Schmidt, B | 1 |
| Horowitz, G | 1 |
| Dolgoff, J | 1 |
| Hamilton, J | 1 |
| Quist, WC | 1 |
| Nishikimi, T | 1 |
| Tani, T | 1 |
| Ohmura, T | 1 |
| Yamagishi, H | 1 |
| Yanagi, S | 1 |
| Yoshiyama, M | 1 |
| Toda, I | 1 |
| Teragaki, M | 1 |
| Akioka, K | 1 |
| Takeuchi, K | 1 |
2 other studies available for candesartan cilexetil and Aortic Diseases
| Article | Year |
|---|---|
Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Arteriosclerosis; Benzimid | 2004 |
Angiotensin II type-1 receptor antagonist as well as angiotensin converying enzyme inhibitor attenuates the development of heart failure in aortocaval fistula rats.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; An | 1995 |